Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Erlotinib can cause hair loss as a side effect.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

M. restricta may cause Malassezia folliculitis, especially in teens and twenties.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Ringworm around the eyes often gets misdiagnosed, leading to eyelash loss, but antifungal treatment can improve the condition.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Malassezia folliculitis mainly affects the trunk in males and is better detected with d-PAS staining.

Many women with hard-to-treat acne also have PCOS.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Medicinal plants may be an effective alternative for treating acne.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

A benign tumor developed at a girl's BCG vaccination site, not previously linked to the vaccine.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Early treatment of acne is important to prevent scarring and improve appearance, using medications that can have side effects.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

A rare scalp disease causes hair loss, pus-filled nodules, and scarring.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.

Lower ghrelin levels and certain gene variations may increase acne risk.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.